OPNAVINST 6100.3 DEPLOYMENT HEALTH (DHA) PROCESS

Question 1

Purpose. To establish policy and procedures to ensure
timely and accurate completion of Deployment Health Assessments
(DHAs) for Active Component (AC) and Reserve Component (RC)
servicemernbers, and to provide the process for reporting
compliance to the Chief of Naval Operations (CNO).

Answer 1

Servicemembers often rate their general health
as worse 3 to 6 months after returning from deployment compared
to their assessments completed within 30 days of redeployment.

Question 2

DHAs consist of three components:
(1) DD 2795, Pre-deployment Health Assessment (Pre-DHA);
(2) DD 2796, Post Deployment Health Assessment (PDHA);
and,
(3) DD 2900, Post Deployment Health Re-assessment
( PDHRA) .

Answer 2

AC and RC servicemembers and commissioned units are
deploying, deployed, and re-deployed (those who have returned
from deployment) under one or more of the following conditions:
(1) Deployment ashore of more than 30 days with duties
involving outside the continental United States operations
without a fixed U.S. Military Treatment Facility (MTF)

(3) Commander exercising operational control (regardless
of deployment area, duration, or MTF support) determines a
health threat exists (e.g., a deployed ship conducts operations
that may expose servicemembers to contaminants, disease, or
traumatic events).

Question 3

Servicemembers assigned to ships and squadrons
conducting routine deployments with their ship or squadron are
exempt from the DHA requirement, unless paragraph 3a(l) or 3a(3)
applies.

Answer 3

The appropriate DHA will be completed in the required
timeframe and be reviewed in a face-to-face interview per
reference (a) with a health care provider.

Question 4

The DD 2795 shall be administered at home station or
at a Navy Mobilization Processing Site (NMPS) no earlier than 60
days prior to the expected deployment date.

Answer 4

The DD 2796 shall be completed as close to the
redeployment date as possible, but not earlier than 30 days before the expected redeployment date and not later than 30 days after redeployment; and, for RC servicemembers, before they are released from active duty.

Question 5

The DD 2900 shall be administered and completed 90

to 180 days after returning from deployment.

Answer 5

a) Servicemembers who deploy for more than one 30
day period in 12 months (frequent deployers) shall receive an
annual concurrent PDHRA and PHA.

Question 6

Servicemembers separating from service prior to
the 90 to 180 day window shall receive a concurrent PDHRA and
separation health assessment

Answer 6

Servicemembers who received wounds or injuries,
that required hospitalization or extended treatment at an MTF
before returning to their home station, will have their
reassessment conducted 90 to 180 days after returning to the home station.

Question 7

All DHAs must be completed and submitted - electronically at https://www nmcphc.med.navy.mil/edha/.

Answer 7

A printed copy of the completed DHA form that has
been electronically signed by a health care provider shall be
kept in the medical treatment record.

Question 8

Rotational Force Commands (AC and RC commands/units that deploy as a unit) shall ensure: 1) Servicemembers complete a DD 2795 within 60 days of expected deployment date; 2) Servicemembers complete a DD 2796 within 30 days before or after returning from deployment to AOR;

Answer 8

NOSCs and RC unit commanders shall: Ensure servicemembers complete the DD 2900 between 90
and 180 days after return from deployment to home station.